Matthew T. Roe, MD

Article

Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

Author:: Matthew T. Roe, MD

Publish date: February 1, 2000

These potent antiplatelet agents constitute a breakthrough, but questions remain about their safety, cost-effectiveness, and proper empiric use. Wi...

Article

Abciximab prevents ischemic complications during angioplasty

Author:: Matthew T. Roe, MD

Publish date: May 1, 1998

The platelet glycoprotein IIb/IIIa inhibitor abciximab, together with heparin in a low, weight-adjusted dose, markedly reduce the risk of acute isc...